We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Higher Blood Lead Levels Lower IQ

By LabMedica International staff writers
Posted on 22 May 2013
Children living near toxic waste sites may experience higher blood lead levels, resulting in a loss of intelligence quotient (IQ) points. More...


Children from lower and middle-income countries in Asia who live near such sites may also suffer a higher incidence of mental retardation.

Scientists at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) collaborating with the Blacksmith Institute (New York, NY, USA) measured lead levels in soil and drinking water at 200 toxic waste sites in 31 countries then estimated the blood lead levels in 779,989 children who were potentially exposed to lead from these sites in 2010.

The blood lead levels ranged from 1.5 to 104 µg/dL, with an average of 21 µg/dL in children ages four years and younger. The average blood lead level in an American child is approximately 1.3 µg/dL. These higher blood lead levels could result in an estimated loss of five to eight IQ points per child and an incidence of mild mental retardation in six out of every 1,000 children. The condition of mental retardation is defined as having an IQ below 70.

Kevin Chatham-Stephens, MD, Pediatric Environmental Health Fellow and coauthor of the study, said, “We found an average predicted blood lead level of 21 µg/dL, which is very high. Lead has serious, long-term health consequences such as the potential to impair cognitive development in children and cause mental retardation. We have shown that children who were chronically exposed to toxic waste sites in lower and middle income countries could have had high lead blood levels."

Philip Landrigan, MD, MSc, Dean for Global Health at the Icahn School of Medicine and coauthor of the study, said, “On a global level, this analysis highlights the importance of assigning more public health resources to identify, evaluate and remediate lead-contaminated toxic waste sites in countries like India, Philippines and Indonesia. In order to prevent further detrimental effects on neurodevelopment in children, these countries should create programs to identify toxic wastes and reduce lead exposure." The study was presented on May 6, 2013, at the Pediatric Academic Societies (PAS) annual meeting held in Washington DC (USA).

Related Links:
Icahn School of Medicine at Mount Sinai
Blacksmith Institute



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.